Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Longeveron Inc. (LGVN) Profit Margins

Over the twelve months to 2026-06-30, Longeveron Inc. (LGVN) had gross margin 69.8%, operating margin -1992.8%, net margin -1977.6%, free cash flow margin -1729.9%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

LGVNLongeveron Inc.Follow LGVN — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
5.1M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days
LineFY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Gross margin—45.2%40.7%31.2%78.8%67.0%69.8%
Operating margin—-1336.6%-1476.5%-2966.0%-690.7%-1942.2%-1992.8%
Net margin—-1305.1%-1541.3%-3020.2%-667.8%-1893.6%-1977.6%
FCF margin—-763.1%-1189.7%-2722.6%-607.1%-1575.5%-1729.9%

USD millions · SEC XBRL

Longeveron Inc. — questions

What is Longeveron Inc.'s gross margin?
69.8% over the twelve months to 2026-06-30.
What is Longeveron Inc.'s operating margin?
-1992.8% over the twelve months to 2026-06-30.
What is Longeveron Inc.'s net profit margin?
-1977.6% over the twelve months to 2026-06-30.

Every figure on this page comes from Longeveron Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.